echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Ibrain fulaxin protects cortical neurons from neonatal hypoxic-ischemic encephalopathy by upregulating vascular endothelial growth factor

    Ibrain fulaxin protects cortical neurons from neonatal hypoxic-ischemic encephalopathy by upregulating vascular endothelial growth factor

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    Neonatal hypoxic-ischemic encephalopathy (NHIE) is a perinatal neonatal brain injury disease caused by hypoxia, manifested by cell damage, metabolic disorders, vascular dysregulation disorders, and decreased



    The objective of this study was to explore the potential mechanism



    To assess the expression and localization of VEGF in HI rat neurons, the researchers performed VEGF and NeuN immunofluorescence double staining



    Figure 1 Effect of xanthanin on the growth of neurons expressing VEGF


    Members of the caspase-3 and Caspase-7 families of cysteine aspartate protease (Caspase) are known to be executive proteins for apoptosis[3].



    Figure 2 Changes in factors and mRNA levels interacting with VEGF


    In summary, in this study, the researchers found that HI injury can lead to severe nerve damage and cerebral infarction, and the protein chip data revealed differential expression of VEGF in cortical, hippocampal, and lung tissues and its co-localization with neurons



    Scan the QR code to read the original text

    https://onlinelibrary.



    References

    [1] Ballot D E, Rakotsoane D, Cooper P A, Ramdin T D, Chirwa T, Pepper M S.
    A prospective observational study of developmental outcomes in survivors of neonatal hypoxic ischaemic encephalopathy in south africa.
    S Afr Med J.
    2020; 110(4):308-312.

    [2] Fernandez-Lopez D, Martinez-Orgado J, Casanova I, Bonet B, Leza J C, Lorenzo P, Moro M A, Lizasoain I.
    Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy.
    J Neurosci Methods.
    2005; 145(1-2):205-212.

    [3] Deng C, Li J, Li L, Sun F, Xie J.
    Effects of hypoxia ischemia on caspase-3 expression and neuronal apoptosis in the brain of neonatal mice.
    Exp Ther Med.
    2019; 17(6):4517-4521.

    About Ibrain

    Ibrain is a global leader in research and education, an English-language open access journal
    in neuroscience published by Wiley and hosted by the Affiliated Hospital of Zunyi Medical University.

    The journal publishes cutting-edge research on the brain, spinal cord and nerves, providing neuroscientists with a platform
    for basic and translational medicine and clinical practice.

    Ibrain is edited by Professor Wang Tinghua, Director of the Laboratory of Neurological Diseases at West China Hospital, Sichuan University, and Professor Xin-Fu Zhou of the University of South Australia
    .

    Journal publication scope and topics:

    Ibrain is interested in topics related to brain, spinal cord, and neurological diseases, including, but not limited to, clinical medicine, molecular diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology, and artificial intelligence
    .

    The journal focuses on clinical and experimental research advances, providing characterization, pathogenesis, diagnosis, treatment, medical innovations and technologies for brain, spinal cord and neurological diseases
    .

    Topics published in the journal include, but are not limited to:

    Types of journal articles published:

    • Original article

    • Reviews

    • Comments

    • Case reports

    • Letter

    • Methods

    Journals in 2022-2024 are exempt from publication fees (APCs
    ).

    Currently, Ibrain is included in the international search database DOAJ, and it takes only two months
    from the filing of the application to the time it is included in the DOAJ.

    We sincerely welcome researchers, doctors and graduate students in the field of neuroscience to actively submit articles to the journal!

    Submission Links:

    https://mc.
    manuscriptcentral.
    com/ibra

    Special Issue Call for Papers

    Ibrain will publish a special issue publishing the latest basic and clinical research
    on CNS injury injection materials.

    It will focus on the molecular mechanisms of the use of injectable materials to repair brain injuries, basic and clinical studies of effective injection materials, and related topics
    .

    We cordially invite researchers to provide original research papers or review articles
    for this special issue.

    We can waive your publication fee and provide authors with fast access to
    publication.

    https://onlinelibrary.
    wiley.
    com/page/journal/27692795/themed-collections/injectable_materials

    Related Reading

    • Expert report playback | 2022 Ibrain Journals Annual Conference & 2nd International Neuroscience Summit Forum
    • Ibrain | Ultrasound-guided peripheral trunk block technology: a new approach that is gradually taking the stage of clinical anesthesia
    • Good news | Congratulations to Ibrain for being included in the DOAJ database!
    • Ibrain | Study on the role of sevoflurane in cognitive function in elderly rats based on cortical microglia activation

    Content | Imperio

    Proofreading and adaptation | Xiong Liulin, Tina

    Wiley is a global leader in research and education, inspiring human potential
    by facilitating discovery, empowering education, and shaping talent.

    For more than 200 years, Wiley has driven the development of a
    global knowledge ecosystem.

    Today, our high-impact content, platforms, and services help researchers, learners, institutions, and businesses achieve their goals
    in a rapidly changing world.

    Wiley, headquartered in Hoboken, New Jersey, USA, is listed on the New York Stock Exchange under the symbols WLY and WLYB
    .

    Like, watch, share, have a one-click triple!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.